electroCore, Inc. (ECOR): Price and Financial Metrics


electroCore, Inc. (ECOR)

Today's Latest Price: $1.77 USD

0.05 (2.91%)

Updated Jan 15 4:00pm

Add ECOR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ECOR Stock Summary

  • electroCore Inc's stock had its IPO on June 22, 2018, making it an older stock than merely 6.88% of US equities in our set.
  • With a price/sales ratio of 24.11, electroCore Inc has a higher such ratio than 91.18% of stocks in our set.
  • As for revenue growth, note that ECOR's revenue has grown 55.67% over the past 12 months; that beats the revenue growth of 90.64% of US companies in our set.
  • Stocks that are quantitatively similar to ECOR, based on their financial statements, market capitalization, and price volatility, are RMED, XENT, EKSO, CUTR, and REFR.
  • ECOR's SEC filings can be seen here. And to visit electroCore Inc's official web site, go to www.electrocore.com.

ECOR Stock Price Chart Interactive Chart >

Price chart for ECOR

ECOR Price/Volume Stats

Current price $1.77 52-week high $3.30
Prev. close $1.72 52-week low $0.32
Day low $1.70 Volume 903,700
Day high $1.84 Avg. volume 499,740
50-day MA $1.61 Dividend yield N/A
200-day MA $1.44 Market Cap 80.45M

electroCore, Inc. (ECOR) Company Bio


electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. It is developing gammaCore, a prescription-only vagus nerve stimulation therapy, for the acute treatment of pain associated with migraine and episodic cluster headache in adults. The company was founded in 2005 and is based in Basking Ridge, New Jersey.


ECOR Latest News Stream


Event/Time News Detail
Loading, please wait...

ECOR Latest Social Stream


Loading social stream, please wait...

View Full ECOR Social Stream

Latest ECOR News From Around the Web

Below are the latest news stories about electroCore Inc that investors may wish to consider to help them evaluate ECOR as an investment opportunity.

electroCore expects FY20 revenue at upper end of $3.3M to $3.5M

electroCore ([[ECOR]] -2.4%) expects the FY20 revenue to be at the upper end of the announced guidance range of $3.3M to $3.5M (+40% Y/Y) vs. $3.39M consensus.Net cash used during 4Q20 is expected to be ~$3.7M; and for the FY20 net cash used was ~$20.2M, representing a 55% decline from...

Seeking Alpha | January 11, 2021

electroCore gains on distribution deal for gammaCore Sapphire in Eastern Europe

electroCore (ECOR) has entered into an agreement with Pro Medical Baltic ((PMB)), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire non-invasive vagus nerve stimulation (nVNS) to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine. PMB currently distributes neuromodulation devices such as implantable vagus...

Seeking Alpha | December 22, 2020

Electrocore Inks Distribution Deal For Migraine Treatment In Eastern Europe; Shares Surge 8%

Electrocore announced a three-year agreement for Pro Medical Baltic UAB (PMB) to be the exclusive distributor of gammaCore Sapphire to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan, and Ukraine. Shares rose 8% at pre-market trading on Tuesday. GammaCore Sapphire, is a non-invasive vagus nerve stimulation (nVNS) treatment, which helps in the preventive treatment of migraine and cluster headache, and acute treatment of pain associated with migraine and episodic cluster headache. Electrocore (ECOR) , a commercial-stage bioelectronic medicine company said that the the initial term of the agreement is for three years.

Anusuya Lahiri on TipRanks | December 22, 2020

electroCore, Inc. Announces Agreement with Pro Medical Baltic to be Exclusive Distributor for gammaCore Sapphire™ in Eastern Europe

ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement with Pro Medical Baltic UAB (“PMB”), whereby PMB will serve as the exclusive distributor of gammaCore Sapphire™ non-invasive vagus nerve stimulation (“nVNS”) to patients suffering from primary headache disorders in Lithuania, Latvia, Belarus, Kazakhstan and Ukraine. “We are delighted to partner with Pro Medical Baltic to be able to introduce our nVNS therapy to new patients in Eastern Europe,” said Iain Strickland, electroCore’s Vice President of European Operations. “Pro Medical Baltic already has experience working with neuromodulation products, and we look forward to supporting their market access...

Yahoo | December 21, 2020

electroCore Announces Positive Top-Line Results from PREMIUM II Migraine Prevention Study

BASKING RIDGE, N.J., Dec. 08, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today top-line results from its GM-US-10 (PREMIUM II) study. Despite the early termination of the study in April 2020 due to the COVID-19 pandemic, all study endpoints, including several patient-assessed quality of life measures, showed benefit from non-invasive vagus nerve stimulation (nVNS), with many endpoints showing a statistically significant improvement with nVNS compared to sham stimulation. In the predefined modified intent to treat population (mITT; n=113), which was the designated primary analysis population for the study, patients using gammaCore™ nVNS had 3.1 less migraine days over the final four weeks of the 12 week double ...

Yahoo | December 8, 2020

Read More 'ECOR' Stories Here

ECOR Price Returns

1-mo 5.99%
3-mo 5.99%
6-mo 5.36%
1-year N/A
3-year N/A
5-year N/A
YTD 13.46%
2020 -1.89%
2019 -74.60%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8126 seconds.